Relmada Therapeutics Inc. Completes $8.0 Million Capital Raise in Series A Financing

By WebmasterOctober 1, 2013November 1st, 2024No Comments

Relmada Therapeutics Inc. Completes $8.0 Million Capital Raise in Series A Financing
Read more here

Previous PostThe Future of Drug Discovery: Two Required Supplements to Current Practices
Next PostActelion Closes Acquisition of Privately-held Ceptaris Therapeutics